US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 51.400
  • +0.250+0.49%
Close Dec 20 16:00 ET
  • 52.550
  • +1.150+2.24%
Post 20:01 ET
5.39BMarket Cap40.79P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
47.69%182.55M
39.15%163.8M
38.95%146.81M
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
Operating revenue
47.69%182.55M
39.15%163.8M
38.95%146.81M
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
Cost of revenue
74.29%2.87M
60.36%2.52M
82.90%2.54M
20.35%6.48M
26.82%1.88M
22.85%1.65M
19.60%1.57M
10.88%1.39M
1.97%5.39M
9.31%1.48M
Gross profit
47.33%179.68M
38.86%161.27M
38.37%144.27M
20.03%475.89M
31.46%133.53M
21.48%121.96M
13.79%116.14M
12.80%104.27M
9.92%396.47M
4.21%101.58M
Operating expense
46.60%133.08M
45.20%125.68M
28.36%114.77M
29.87%368.61M
28.81%101.86M
32.61%90.78M
22.54%86.56M
36.16%89.42M
20.16%283.84M
30.05%79.08M
Selling and administrative expenses
62.93%73.75M
54.65%66.94M
15.86%56.27M
20.55%184.26M
11.41%47.15M
28.72%45.26M
14.46%43.28M
29.34%48.56M
24.92%152.85M
31.09%42.32M
Research and development costs
30.36%59.34M
35.74%58.75M
43.22%58.51M
40.74%184.35M
48.85%54.71M
36.72%45.52M
31.84%43.28M
45.27%40.85M
15.04%130.99M
28.88%36.75M
Operating profit
49.46%46.6M
20.31%35.59M
98.61%29.5M
-4.75%107.28M
40.76%31.67M
-2.37%31.18M
-5.88%29.58M
-44.51%14.85M
-9.51%112.63M
-38.63%22.5M
Net non-operating interest income expense
21.83%6.35M
79.38%6M
53.39%5.49M
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
Non-operating interest income
21.83%6.35M
79.38%6M
53.39%5.49M
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
Other net income (expense)
Special income (charges)
----
----
----
--0
----
----
----
----
--0
----
Income before tax
45.51%52.94M
26.32%41.6M
89.83%34.99M
7.20%124.56M
51.63%36.81M
10.24%36.39M
2.71%32.93M
-31.34%18.43M
-7.05%116.19M
-33.92%24.28M
Income tax
14.44%5.73M
13.07%6.11M
183.01%7.23M
24.67%18.42M
-28.94%5.45M
412.16%5.01M
16.17%5.4M
-36.94%2.56M
18.24%14.77M
63.89%7.68M
Net income
50.47%47.21M
28.92%35.49M
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
Net income continuous Operations
50.47%47.21M
28.92%35.49M
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
Minority interest income
Net income attributable to the parent company
50.47%47.21M
28.92%35.49M
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
Preferred stock dividends
Other preferred stock dividends
153.88%523K
206K
Net income attributable to common stockholders
49.78%46.69M
28.38%35.12M
74.06%27.51M
4.15%105.5M
88.37%31.14M
-9.78%31.17M
-0.15%27.36M
-30.66%15.81M
-9.98%101.29M
-48.42%16.53M
Basic earnings per share
45.16%0.45
25.93%0.34
80.00%0.27
7.37%1.02
100.00%0.3
-3.13%0.31
3.85%0.27
-31.82%0.15
-2.06%0.95
-46.43%0.15
Diluted earnings per share
46.43%0.41
28.00%0.32
78.57%0.25
8.05%0.94
100.00%0.28
-6.67%0.28
4.17%0.25
-30.00%0.14
-2.25%0.87
-46.15%0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 47.69%182.55M39.15%163.8M38.95%146.81M20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M
Operating revenue 47.69%182.55M39.15%163.8M38.95%146.81M20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M
Cost of revenue 74.29%2.87M60.36%2.52M82.90%2.54M20.35%6.48M26.82%1.88M22.85%1.65M19.60%1.57M10.88%1.39M1.97%5.39M9.31%1.48M
Gross profit 47.33%179.68M38.86%161.27M38.37%144.27M20.03%475.89M31.46%133.53M21.48%121.96M13.79%116.14M12.80%104.27M9.92%396.47M4.21%101.58M
Operating expense 46.60%133.08M45.20%125.68M28.36%114.77M29.87%368.61M28.81%101.86M32.61%90.78M22.54%86.56M36.16%89.42M20.16%283.84M30.05%79.08M
Selling and administrative expenses 62.93%73.75M54.65%66.94M15.86%56.27M20.55%184.26M11.41%47.15M28.72%45.26M14.46%43.28M29.34%48.56M24.92%152.85M31.09%42.32M
Research and development costs 30.36%59.34M35.74%58.75M43.22%58.51M40.74%184.35M48.85%54.71M36.72%45.52M31.84%43.28M45.27%40.85M15.04%130.99M28.88%36.75M
Operating profit 49.46%46.6M20.31%35.59M98.61%29.5M-4.75%107.28M40.76%31.67M-2.37%31.18M-5.88%29.58M-44.51%14.85M-9.51%112.63M-38.63%22.5M
Net non-operating interest income expense 21.83%6.35M79.38%6M53.39%5.49M385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M
Non-operating interest income 21.83%6.35M79.38%6M53.39%5.49M385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M
Other net income (expense)
Special income (charges) --------------0------------------0----
Income before tax 45.51%52.94M26.32%41.6M89.83%34.99M7.20%124.56M51.63%36.81M10.24%36.39M2.71%32.93M-31.34%18.43M-7.05%116.19M-33.92%24.28M
Income tax 14.44%5.73M13.07%6.11M183.01%7.23M24.67%18.42M-28.94%5.45M412.16%5.01M16.17%5.4M-36.94%2.56M18.24%14.77M63.89%7.68M
Net income 50.47%47.21M28.92%35.49M74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M
Net income continuous Operations 50.47%47.21M28.92%35.49M74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M
Minority interest income
Net income attributable to the parent company 50.47%47.21M28.92%35.49M74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M
Preferred stock dividends
Other preferred stock dividends 153.88%523K206K
Net income attributable to common stockholders 49.78%46.69M28.38%35.12M74.06%27.51M4.15%105.5M88.37%31.14M-9.78%31.17M-0.15%27.36M-30.66%15.81M-9.98%101.29M-48.42%16.53M
Basic earnings per share 45.16%0.4525.93%0.3480.00%0.277.37%1.02100.00%0.3-3.13%0.313.85%0.27-31.82%0.15-2.06%0.95-46.43%0.15
Diluted earnings per share 46.43%0.4128.00%0.3278.57%0.258.05%0.94100.00%0.28-6.67%0.284.17%0.25-30.00%0.14-2.25%0.87-46.15%0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List